ask="N/A"
ask_size="N/A"
average_daily_volume="178698"
bid="0.7000"
bid_size="1000"
book_value="0.7250"
change="+0.0637"
change_from_200_day_moving_average="-0.5747"
change_from_50_day_moving_average="-0.1617"
change_from_52_week_high="-1.3063"
change_From_52_week_low="0.1337"
change_in_percent="+10.1111%"
close="0.6937"
dividend_pay_date="11/8/2012"
dividend_per_share="0.0000"
dividend_yield="0.0000"
earnings_per_share="-0.8100"
ebitda="-30.60M"
eps_estimate_current_year="-0.9300"
eps_estimate_next_quarter="-0.2300"
eps_estimate_next_year="-0.8600"
ex_dividend_date="11/9/2012"
float_shares="30530000"
high="0.7100"
high_52_weeks="2.0000"
last_trade_date="3/16/2017"
last_trade_price="0.6937"
last_trade_size="484"
last_trade_time="4:00pm"
low="0.6100"
low_52_weeks="0.5600"
market_capitalization="26.81M"
moving_average_200_day="1.2684"
moving_average_50_day="0.8554"
name="Aviragen Therapeutics
Inc."
notes="N/A"
one_year_target_price="4.1700"
open="0.6500"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-45.3095%"
percent_change_from_50_day_moving_average="-18.9062%"
percent_change_from_52_week_high="-65.3150%"
percent_change_from_52_week_low="+23.8750%"
previous_close="0.6300"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.8690"
price_per_sales="2.4846"
revenue="9.80M"
shares_outstanding="38649000"
short_ratio="0.6400"
stock_exchange="NMS"
symbol="AVIR"
volume="365128"
weeks_range_52="0.5600 - 2.0000"
